InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
T+90 hit rate
0%
T+90 mean return
-18.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Keen Nicholas, Directeur Scientifique. Officer active across 1 company, notably BICYCLE THERAPEUTICS plc. Cumulatively, 19 reports have been logged. Split: 0 buy · 13 sells. Total volume traded: €1.6m. History available since 14 July 2021. The latest transaction was filed on 3 July 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations19 total
779 shares@ US$19.640.7% of flowOrdinary SharesSEC:0001415889-24-019385:0
790 shares@ US$23.810.9% of flowOrdinary SharesSEC:0001415889-24-010414:0
28,000 shares0Ordinary SharesSEC:0001209191-24-000888:0
272 shares@ US$20.000.3% of flowOrdinary SharesSEC:0001209191-23-052253:0
336 shares@ US$25.100.4% of flowOrdinary SharesSEC:0001209191-23-041570:0
319 shares@ US$21.110.3% of flowOrdinary SharesSEC:0001209191-23-023352:0
17,500 shares0Ordinary SharesSEC:0001209191-23-002193:0
15,000 shares0Ordinary SharesSEC:0001209191-22-001814
15,000 shares0Ordinary SharesSEC:0001209191-22-001814:0
15,477 shares@ US$14.000.039% mcap9.8% of flowOrdinary SharesSEC:0001209191-21-071008:0
15,477 shares@ US$14.009.5% of flowOrdinary SharesSEC:0001209191-21-071008
1,188 shares@ US$45.002.3% of flowOrdinary SharesSEC:0001209191-21-059375
1,188 shares@ US$45.000.0094% mcap2.3% of flowOrdinary SharesSEC:0001209191-21-059375:0
3,000 shares@ US$45.000.023% mcap5.8% of flowOrdinary SharesSEC:0001209191-21-056655:0
3,000 shares@ US$45.005.7% of flowOrdinary SharesSEC:0001209191-21-056655
10,000 shares@ US$40.000.069% mcap17.1% of flowOrdinary SharesSEC:0001209191-21-054789:0
10,000 shares@ US$40.0016.7% of flowOrdinary SharesSEC:0001209191-21-054789
10,000 shares@ US$35.0014.6% of flowOrdinary SharesSEC:0001209191-21-046997
10,000 shares@ US$35.000.060% mcap15.0% of flowOrdinary SharesSEC:0001209191-21-046997:0
19 of 19 declarations
About Keen Nicholas
Nicholas Keen is the Chief Scientific Officer at BICYCLE THERAPEUTICS plc. In this role, he oversees the company's research and development initiatives, focusing on innovation in the biotechnology field. Keen is responsible for scientific direction and strategy formulation for the development of new treatments. His scientific expertise is essential for the success of BICYCLE THERAPEUTICS.
